Momentus Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Momentus Inc. on June 17, 2025. The filing details material amendments to existing financing agreements and the creation of new direct financial obligations. The company is incorporated in Delaware and its Class A common stock trades on the Nasdaq Stock Market under the symbol "MNTS."
Key Financial Metrics and Obligations
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, or operating margins. Instead, it outlines specific debt and equity-related obligations:
- Loan Agreement Amendment: Amended a $1.5 million loan facility with J.J. Astor & Co. (two tranches of $750,000).
- Additional Convertible Note: Issued a junior secured convertible note with an original principal amount of $1,012,500 to secure the second loan tranche.
- Warrant Issuance: Issued a warrant to purchase up to 476,470 shares of Class A common stock.
- Convertible Note Restructuring: Agreed to cancel a $1,200,000 note held by A.G.P./Alliance Global Partners and replace it with a new $500,000 convertible note upon the commencement of a primary offering.
Material Changes and Terms
Significant changes to the terms of the J.J. Astor & Co. loan include:
- Funding Conditions: The second tranche funding is now contingent on the stock price being at least $1.25, market capitalization of at least $6.7 million, and specific trading volume thresholds.
- Conversion Price: Revised to the lesser of $1.70 or the closing price of the stock prior to the issuance of the Additional Convertible Note.
- Make-Whole Provision: Introduced a cash "make-whole" payment upon conversion if the conversion price exceeds the lower of the closing price on the conversion date or the 20-day volume-weighted average price.
- Termination Fee: If the company raises equity sufficient to repay the initial note before the additional funding date, it must pay a $100,000 termination fee to the lender.
- Stockholder Approval: The company must call a stockholder meeting within 90 days of issuing the Additional Convertible Note to approve the amended agreement.
Regarding the A.G.P. note, the new $500,000 note will mature 18 months after issuance with a conversion price of $1.67 per share and includes a 180-day lock-up period.
Outlook, Risks, and Contingencies
The filing highlights several risks and contingencies tied to the company's liquidity and stock performance:
- Market Conditions: Access to the second tranche of the $1.5 million loan is strictly dependent on maintaining specific stock price, market cap, and volume levels.
- Dilution Risk: The issuance of convertible notes and warrants introduces potential dilution to existing shareholders.
- Equity Offering Dependency: The restructuring of the A.G.P. note is contingent on the commencement of a primary equity offering.
- Regulatory Compliance: The securities were sold unregistered under Section 4(a)(2) and Rule 506(b) exemptions.
Key Facts for Investor Verification
- Verify the current trading price, market capitalization, and average trading volume of MNTS to assess the likelihood of funding the second loan tranche.
- Confirm the status of any planned primary equity offering, which is a trigger for the A.G.P. note restructuring.
- Monitor the timeline for the required stockholder meeting to approve the amended loan agreement.
- Review the potential dilution impact of the 476,470 warrant shares and the convertible notes totaling over $1.5 million in principal.
- Check for any subsequent filings regarding the effectiveness of the resale shelf registration statement mentioned in the warrant terms.